ConductScience.org, home

Paper8442002

Synergistic neurotoxic effects of styrene oxide and acrylamide: glutathione-independent necrosis of cerebellar granule cells.

Beiswanger CM and 4 others. Toxicol Appl Pharmacol, 1993. Cited by 22 papers, by iCite.

Cite this record

ConductScience Library. Synergistic neurotoxic effects of styrene oxide and acrylamide: glutathione-independent necrosis of cerebellar granule cells. Papers, record 8442002. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/8442002

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Synergistic neurotoxic effects of styrene oxide and acrylamide: glutathione-independent necrosis of cerebellar granule cells.
PubMed
Journal
Toxicol Appl Pharmacol
PubMed
Year
1993
PubMed
Publication types
Journal Article, Research Support, U.S. Gov't, P.H.S.
PubMed
Citations, by iCite
22
iCite
Relative citation ratio, by iCite
1.1
iCite
Revised in PubMed
2017-11-16
PubMed

Authors5

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Beiswanger CMC M
2Mandella RDR D
3Graessle TRT R
4Reuhl KRK R
5Lowndes HEH E

Source PubMed

Download CSV of authors

Topics15

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
AcrylamidesMajor topic
CerebellumMajor topic
Epoxy CompoundsMajor topic
GlutathioneMajor topic
Acrylamide
Animals
Drug Synergism
Female
Ganglia, Spinal
Glutathione Transferase
Maleates
Necrosis
Pyridines
Rats
Rats, Sprague-Dawley

Source PubMed

Download CSV of topics

Grants3

Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.

Grant, as the record writes itAgencyCountryNIH projectStated bySource
ES-04976NIEHS NIH HHSUnited StatesR01ES004976PubMed and NIHNIH RePORTER
ES-05022NIEHS NIH HHSUnited StatesPubMedPubMed
NS-23325NINDS NIH HHSUnited StatesR01NS023325PubMed and NIHNIH RePORTER

Download CSV of grants

Cited by5

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 22 citations.

PMIDTitleJournalYearIn PapersSource
26185593Melatonin Attenuates Oxidative Damage Induced by Acrylamide In Vitro and In Vivo.Oxid Med Cell Longev2015https://conductscience.org/library/papers/26185593PubMed
18470611Effects of acrylamide on the nervous tissue antioxidant system and sciatic nerve electrophysiology in the rat.Neurochem Res2008https://conductscience.org/library/papers/18470611PubMed
11760118Application of the S-pyridylethylation reaction to the elucidation of the structures and functions of proteins.J Protein Chem2001https://conductscience.org/library/papers/11760118PubMed
11160988
Neurobehavioural changes and persistence of complaints in workers exposed to styrene in a polyester boat building plant: influence of exposure characteristics and microsomal epoxide hydrolase phenotype.
Occup Environ Med2001https://conductscience.org/library/papers/11160988PubMed
8024461A physiologic pharmacokinetic model for styrene and styrene-7,8-oxide in mouse, rat and man.Arch Toxicol1994https://conductscience.org/library/papers/8024461PubMed

Download CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Trials
  • Comments and corrections
  • References
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/8442002

GET https://conductscience.org/api/papers/v1/8442002/authors